(S (NP (NP (NNP Parkinson) (POS 's)) (NN disease)) (VP (VBZ is) (NP (NP (DT a) (JJ neurodegenerative) (NN disease)) (SBAR (WHNP (WDT that)) (S (VP (MD can) (VP (VB affect) (NP (NP (NP (DT a) (NN person) (POS 's)) (NN movement)) (, ,) (NP (NN speech) (, ,) (NN dexterity) (, ,) (CC and) (NN cognition))))))))) (. .))
(S (NP (NNS Clinicians)) (ADVP (RB primarily)) (VP (VB diagnose) (NP (NP (NNP Parkinson) (POS 's)) (NN disease)) (PP (IN by) (S (VP (VBG performing) (NP (NP (DT a) (JJ clinical) (NN assessment)) (PP (IN of) (NP (NNS symptoms)))))))) (. .))
(S (ADVP (RB However)) (, ,) (NP (NNS misdiagnoses)) (VP (VBP are) (ADJP (JJ common))) (. .))
(S (NP (NP (CD One) (NN factor)) (SBAR (WHNP (WDT that)) (S (VP (VBZ contributes) (PP (IN to) (NP (NNS misdiagnoses))))))) (VP (VBZ is) (SBAR (IN that) (S (NP (NP (DT the) (NNS symptoms)) (PP (IN of) (NP (NP (NNP Parkinson) (POS 's)) (NN disease)))) (VP (MD may) (RB not) (VP (VB be) (ADJP (JJ prominent) (PP (IN at) (NP (NP (DT the) (NN time)) (SBAR (S (NP (DT the) (JJ clinical) (NN assessment)) (VP (VBZ is) (VP (VBN performed))))))))))))) (. .))
(S (ADVP (RB Here)) (, ,) (NP (PRP we)) (VP (VBP present) (NP (NP (NP (DT a) (NML (NN machine) (HYPH -) (NN learning)) (NN approach)) (PP (IN towards) (S (VP (VBG distinguishing) (PP (IN between) (NP (NNS people))) (PP (IN with) (CC and) (IN without) (S (NP (NP (NNP Parkinson) (POS 's)) (NN disease)) (VP (VBG using) (NP (NP (ADJP (NP (NP (NML (JJ long) (HYPH -) (NN term)) (NNS data)) (PP (IN from) (NP (NN smartphone)))) (HYPH -) (VBN based)) (NN walking)) (, ,) (NP (NN voice)) (, ,) (VP (VBG tapping)))))))))) (CC and) (NP (NN memory) (NNS tests)))) (. .))
(S (NP (PRP We)) (VP (VBP demonstrate) (SBAR (IN that) (S (NP (PRP$ our) (NML (ADJP (JJ attentive) (JJ deep)) (HYPH -) (NN learning)) (NNS models)) (VP (VBP achieve) (NP (JJ significant) (NNS improvements)) (PP (IN in) (NP (NP (JJ predictive) (NN performance)) (PP (IN over) (NP (NP (NP (JJ strong) (NNS baselines)) (-LRB- -LRB-) (NP (NP (NN area)) (PP (IN under) (NP (NP (DT the) (NN receiver)) (VP (VBG operating) (S (NP (JJ characteristic) (NN curve)) (VP (SYM =) (NP (CD 0.85)))))))) (-RRB- -RRB-)) (PP (IN in) (NP (NP (NNS data)) (PP (IN from) (NP (NP (DT a) (NN cohort)) (PP (IN of) (NP (CD 1853) (NNS participants))))))))))))))) (. .))
(S (NP (PRP We)) (ADVP (RB also)) (VP (VBP show) (SBAR (IN that) (S (NP (PRP$ our) (NNS models)) (VP (VBP identify) (NP (JJ meaningful) (NNS features)) (PP (IN in) (NP (DT the) (NN input) (NNS data))))))) (. .))
(S (NP (PRP$ Our) (NNS results)) (VP (VBP confirm) (SBAR (IN that) (S (NP (NP (NN smartphone) (NNS data)) (VP (VBN collected) (PP (IN over) (NP (NP (VBN extended) (NNS periods)) (PP (IN of) (NP (NN time))))))) (VP (MD could) (PP (IN in) (NP (DT the) (JJ future))) (ADVP (RB potentially)) (VP (VB be) (VP (VBN used) (PP (IN as) (NP (NP (DT a) (JJ digital) (NN biomarker)) (PP (IN for) (NP (NP (DT the) (NN diagnosis)) (PP (IN of) (NP (NP (NNP Parkinson) (POS 's)) (NN disease))))))))))))) (. .))
